Agarwood essential oil inhalation exerts antianxiety and antidepressant effects via the regulation of Glu/GABA system homeostasis

Wang,Canhong; Gong,Bao; Liu,Yangyang; Chen,Deli; Wu,Yulan; Wei,Jianhe

doi:10.3892/br.2023.1598

Agarwood essential oil inhalation exerts antianxiety and antidepressant effects via the regulation of Glu/GABA system homeostasis

Authors:
- Canhong Wang
- Bao Gong
- Yangyang Liu
- Deli Chen
- Yulan Wu
- Jianhe Wei
View Affiliations

Affiliations: Hainan Branch of The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Haikou, Hainan 570311, P.R. China, Hainan Branch of The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Haikou, Hainan 570311, P.R. China
Published online on: January 17, 2023 https://doi.org/10.3892/br.2023.1598
Article Number: 16
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Depression and anxiety are common diseases that endanger the physical and mental health of individuals. Agarwood incense inhalation has been used as a traditional Chinese medicine for relaxation and to improve sleep for centuries. In a previous study by the authors it was demonstrated that agarwood essential oil (AEO) injection exerted anxiolytic and antidepressant effects. Therefore the present study further investigated the anxiolytic and antidepressant effects of AEO inhalation on anxiolytic mice induced by M‑chlorophenylpiperazine and depressive mice induced by chronic unpredictable mild stress. The results demonstrated that AEO exerted a significant anxiolytic effect, whereby autonomous movements were inhibited during the light dark exploration test and open field test. Furthermore, the tail suspension test and the forced swimming test demonstrated that AEO also exerted an antidepressant effect, whereby the immobility times were decreased. Moreover, AEO was determined to increase the levels of 5‑hydroxytryptamine, γ‑aminobutyric acid (GABA) A receptor (GABAA) and glutamate (Glu) in anxiolytic mice and inhibit the levels of GABAA and Glu in depressive mice. Further investigations into how AEO affected the Glu/GABA system demonstrated that AEO markedly increased the protein expression levels of GABA transaminase (GABAT), glutamate metabotropic receptor 5 (GRM5), glutamate ionotropic receptor AMPA type subunit 1 (GluR1) and vesicular glutamate transporter 1 (VGluT1). Furthermore, AEO reduced the expression levels of GABAT, glutamate ionotropic receptor NMDA type subunit 2B and GRM5, and enhanced the expression levels of GluR1 and VGluT1. These results demonstrated that AEO potentially possesses antianxiety and antidepressant properties. The present study determined that the mechanism was related to the regulation of Glu/GABA neurotransmitter system homeostasis.

View Figures

View References

1	World Health Organization. depression and other common mental disorders: Global health estimates. World Health Organization, Geneva, 2017. https://doi.org/CC BY-NC-SA 3.0 IGO.
2	Guze SB and Robins E: Suicide and primary affective disorders. Br J Psychiatry. 117:437–438. 1970.PubMed/NCBI View Article : Google Scholar
3	Duman RS and Aghajanian GK: Synaptic dysfunction in depression: Potential therapeutic targets. Science. 338:68–72. 2012.PubMed/NCBI View Article : Google Scholar
4	Anisman H and Matheson K: Stress, depression, and anhedonia: Caveats concerning animal models. Neurosci Biobehav Rev. 29:525–546. 2005.PubMed/NCBI View Article : Google Scholar
5	Grillo L: A possible role of anhedonia as common substrate for depression and anxiety. Dep Res Treat. 2016(1598130)2016.PubMed/NCBI View Article : Google Scholar
6	Miller BR and Hen R: The current state of the neurogenic theory of depression and anxiety. Curr Opin Neurobiol. 30:51–58. 2015.PubMed/NCBI View Article : Google Scholar
7	Yu W, Wang L, Yang L, Li YJ, Wang M, Qiu C, Yang Q, Li XB, Huang YL, Liu R and Wu YM: Activation of LXRβ signaling in the amygdala confers anxiolytic effects through rebalancing excitatory and inhibitory neurotransmission upon acute stress. Neurotherapeutics. 17:1253–1270. 2020.PubMed/NCBI View Article : Google Scholar
8	Murrough JW, Abdallah CG and Mathew SJ: Targeting glutamate signalling in depression: Progress and prospects. Nat Rev Drug Discov. 16:472–486. 2017.PubMed/NCBI View Article : Google Scholar
9	Xie W, Cai L, Yu Y, Gao L, Xiao L, He Q, Ren Z and Liu Y: Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation. 11(41)2014.PubMed/NCBI View Article : Google Scholar
10	Chaves EMC, Honório-Júnior JER, Sousa CNS, Monteiro VS, Nonato DTT, Dantas LP, Lúcio ASSC, Barbosa-Filho JM, Patrocínio MCA, Viana GSB and Vasconcelos SMM: The anxiolytic-like effect of 6-styryl-2-pyrone in mice involves GABAergic mechanism of action. Metab Brain Dis. 33:139–149. 2018.PubMed/NCBI View Article : Google Scholar
11	Pham TH, Defaix C, Nguyen TML, Mendez-David I, Tritschler L, David DJ and Gardier AM: Cortical and raphe GABA_A, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine. Pharmcol Biochem Beha. 192(172913)2020.PubMed/NCBI View Article : Google Scholar
12	Sun H, Guan L, Zhu Z and Li H: Reduced levels of NR1 and NR2A with depression-like behavior in different brain regions in prenatally stressed juvenile offspring. PLoS One. 8(e81775)2013.PubMed/NCBI View Article : Google Scholar
13	Gasull-Camós JL, Martínez-Torres SL, Tarrés-Gatius M, Ozaita A, Artigas F and Castañé A: Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex. Neuropharmacology. 139:41–51. 2018.PubMed/NCBI View Article : Google Scholar
14	CITES: Amendments to appendices I and II of the convention - adopted by the Conference of the Parties at its 13th meeting, Bangkok Thailand, 2-14 October, 2004.
15	Hashim YZ, Kerr PG, Abbas P and Mohd Salleh H: Aquilaria spp. (agarwood) as source of health beneficial compounds: A review of traditional use, phytochemistry and pharmacology. J Ethnopharmacol. 189:331–360. 2016.PubMed/NCBI View Article : Google Scholar
16	Korinek M, Wagh VD, Lo IW, Hsu YM, Hsu HY, Hwang TL, Wu YC, Cheng YB, Chen BH and Chang FR: Antiallergic phorbol ester from the seeds of Aquilaria malaccensis. Int J Mol Sci. 17(398)2016.PubMed/NCBI View Article : Google Scholar
17	National Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China. 1st edition. Chinese Medical Science and Technology Press, Beijing, pp185-186, 2015.
18	Dahham SS, Tabana YM, Iqbal MA, Ahamed MBK, Ezzat MO, Majid ASA and Majid AMSA: The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of Aquilaria crassna. Molecules. 20:11808–11829. 2015.PubMed/NCBI View Article : Google Scholar
19	Wang S, Wang C, Peng D, Liu X, Wu C, Guo P and Wei J: Agarwood essential oil displays sedative-hypnotic effect through GABAergic system. Molecules. 22(2190)2017.PubMed/NCBI View Article : Google Scholar
20	Wang S, Wang C, Yu Z, Wu C, Peng D, Liu X, Liu Y, Yang Y, Guo P and Wei J: Agarwood essential oil ameliorates restrain stress-induced anxiety and depression by inhibiting HPA axis hyperactivity. Int J Mol Sci. 19(3468)2018.PubMed/NCBI View Article : Google Scholar
21	Bahrani H, Mohamad J, Paydar MJ and Rothan HA: Isolation and characterisation of acetylcholinesterase inhibitors from Aquilaria subintegra for the treatment of Alzheimer's disease (AD). Curr Alzheimer Res. 11:206–214. 2014.PubMed/NCBI View Article : Google Scholar
22	Huo HX, Zhu ZX, Pang DR, Li YT, Huang Z, Shi SP, Zheng J, Zhang Q, Zhao YF, Tu PF and Li J: Anti-neuroinflammatory sesquiterpenes from Chinese eaglewood. Fitoterapia. 106:115–121. 2015.PubMed/NCBI View Article : Google Scholar
23	Yang L, Qiao L, Xie D, Yuan Y, Chen N, Dai J and Guo S: 2-(2-phenylethyl)chromones from Chinese eaglewood. Phytochemistry. 76:92–97. 2012.PubMed/NCBI View Article : Google Scholar
24	Takemoto H, Ito M, Shiraki T, Yagura T and Honda G: Sedative effects of vapor inhalation of agarwood oil and spikenard extract and identification of their active components. J Nat Med. 62:41–46. 2008.PubMed/NCBI View Article : Google Scholar
25	Yi Z, Wang W and Zhang J: Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats. Eur J Pharmacol. 504:39–44. 2004.PubMed/NCBI View Article : Google Scholar
26	Guo JY, Wang WJ, Fang HJ, Yin DL, Sun SJ, Liu RW and Li C: Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine. US Patent 6, 486, 201. Filed November 19, 1999; issued November 26, 2002.
27	Yang L, Qiao L, Ji C, Xie D, Gong NB, Lu Y, Zhang J, Dai J and Guo S: Antidepressant abietane diterpenoids from Chinese eaglewood. J Nat Prod. 76:216–222. 2013.PubMed/NCBI View Article : Google Scholar
28	Liu Y, Chen H, Yang Y, Zhang Z, Wei J, Meng H, Chen W, Feng J, Gan B, Chen X, et al: Whole-tree agarwood-inducing technique: an efficient novel technique for producing high-quality agarwood in cultivated Aquilaria sinensis trees. Molecules. 18:3086–3106. 2013.PubMed/NCBI View Article : Google Scholar
29	Treit D and Fundytus M: Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav. 31:959–962. 1988.PubMed/NCBI View Article : Google Scholar
30	Mezzomo NJ, Silveira A, Giuliani GS, Quadros VA and Rosemberg DB: The role of taurine on anxiety-like behaviors in zebrafish: A comparative study using the novel tank and the light-dark tasks. Neurosci Lett. 613:19–24. 2016.PubMed/NCBI View Article : Google Scholar
31	Xie W, Meng X, Zhai Y, Zhou P, Ye T, Wang Z, Sun G and Sun X: Panax notoginseng saponins: A review of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology. Molecules. 23(940)2018.PubMed/NCBI View Article : Google Scholar
32	Wisłowska-Stanek A, Lehner M, Skórzewska A, Krząścik P, Maciejak P, Szyndler J, Ziemba A and Płaźnik A: Changes in the brain expression of alpha-2 subunits of the GABA-A receptor after chronic restraint stress in low- and high-anxiety rats. Behav Brain Res. 253:337–345. 2013.PubMed/NCBI View Article : Google Scholar
33	Modi S, Rana P, Kaur P, Rani N and Khushu S: Glutamate level in anterior cingulate predicts anxiety in healthy humans: A magnetic resonance spectroscopy study. Psychiatry Res. 224:34–41. 2014.PubMed/NCBI View Article : Google Scholar
34	Mathews DC, Henter ID and Zarate CA: Targeting the glutamatergic system to treat major depressive disorder: Rationale and progress to date. Drugs. 72:1313–1333. 2012.PubMed/NCBI View Article : Google Scholar
35	Nuss P: Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatr Dis Treat. 11:165–175. 2015.PubMed/NCBI View Article : Google Scholar
36	Chen S, Huang X, Zeng XJ, Sieghart W and Tietz EI: Benzodiazepine-mediated regulation of alpha1, alpha2, beta1-3 and gamma2 GABA(A) receptor subunit proteins in the rat brain hippocampus and cortex. Neurosciences. 93:33–44. 1999.PubMed/NCBI View Article : Google Scholar
37	Dremencov E, Gur E, Lerer B and Newman ME: Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 27:729–739. 2003.PubMed/NCBI View Article : Google Scholar
38	Tóth K: Glutamatergic neurotransmission in the hippocampus. Springer, New York, 2010.
39	Mokler D, Morgane PJ, Luebke J and Galler JR: Serotonin release and modulation of GABA neurotransmission in the hippocampus of rats exposed to prenatal protein malnutrition. Serotonin: From the Molecule to the ClinicSerotonin: From the Molecule to the Clinic, 2000.
40	Pinheiro AC, da Silva AJ, Prado MA, Cordeiro Mdo N, Richardson M, Batista MC, de Castro Junior CJ, Massensini AR, Guatimosim C, Romano-Silva MA, et al: Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus. Hippocampus. 19:1123–1129. 2009.PubMed/NCBI View Article : Google Scholar
41	Ferreira-Junior NC, Lagatta DC and Resstel LBM: Glutamatergic, GABAergic, and endocannabinoid neurotransmissions within the dorsal hippocampus modulate the cardiac baroreflex function in rats. Pflugers Arch. 470:395–411. 2018.PubMed/NCBI View Article : Google Scholar
42	Stefanits H, Milenkovic I, Mahr N, Pataraia E, Hainfellner JA, Kovacs GG, Sieghart W, Yilmazer-Hanke D and Czech T: GABA_A receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits. J Comp Neurol. 526:324–348. 2018.PubMed/NCBI View Article : Google Scholar
43	Guerriero RM, Giza CC and Rotenberg A: Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 15(27)2015.PubMed/NCBI View Article : Google Scholar
44	Deidda G, Bozarth IF and Cancedda L: Modulation of GABAergic transmission in development and neurodevelopmental disorders: Investigating physiology and pathology to gain therapeutic perspectives. Front Cell Neurosci. 8(119)2014.PubMed/NCBI View Article : Google Scholar
45	Yu H, Li M, Zhou D, Lv D, Liao Q, Lou Z, Shen M, Wang Z, Li M, Xiao X, et al: Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice. Neuropharmacology. 131:209–222. 2018.PubMed/NCBI View Article : Google Scholar
46	Zink M, Vollmayr B, Gebicke-Haerter PJ and Henn FA: Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology. 58:465–473. 2010.PubMed/NCBI View Article : Google Scholar
47	Bi LL, Wang J, Luo ZY, Chen SP, Geng F, Chen YH, Li SJ, Yuan CH, Lin S and Gao TM: Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors. Neuropharmacology. 72:148–156. 2013.PubMed/NCBI View Article : Google Scholar
48	Poulter MO, Du L, Zhurov V, Merali Z and Anisman H: Plasticity of the GABA(A) receptor subunit cassette in response to stressors in reactive versus resilient mice. Neuroscience. 165:1039–1051. 2010.PubMed/NCBI View Article : Google Scholar